BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 7163709)

  • 1. [Use of L-dopa test in acromegaly. Apropos of 6 personal cases].
    Remacle B
    Rev Med Liege; 1982 Dec; 37(23):807-21. PubMed ID: 7163709
    [No Abstract]   [Full Text] [Related]  

  • 2. [Study of growth hormone under the effects of L-dopa in retardation of stature and acromegaly].
    Fossati P; Asfour M; Fourlinnie JC; Cappoen JP; Dalle-Furnari MA; Brion-Brevan B
    Lille Med; 1976 Nov; 19(9):757-65. PubMed ID: 1004102
    [No Abstract]   [Full Text] [Related]  

  • 3. Recovery from paradoxical growth hormone responses in acromegaly after transphenoidal selective adenomectomy.
    Hoyte KM; Martin JB
    J Clin Endocrinol Metab; 1975 Oct; 41(4):656-9. PubMed ID: 809457
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dynamics of growth hormone secretion in untreated acromegaly.
    Dash RJ; Rao NS; Sriprakash ML; Sialy R
    J Assoc Physicians India; 1987 May; 35(5):341-3. PubMed ID: 3121582
    [No Abstract]   [Full Text] [Related]  

  • 5. [L-DOPA loading test].
    Shizume K; Kozuka N
    Nihon Rinsho; 1979 Jun; Suppl():2469-70. PubMed ID: 491189
    [No Abstract]   [Full Text] [Related]  

  • 6. Age changes the diagnostic accuracy of mean profile and nadir growth hormone levels after oral glucose in postoperative patients with acromegaly.
    Colao A; Pivonello R; Cavallo LM; Gaccione M; Auriemma RS; Esposito F; Cappabianca P; Lombardi G
    Clin Endocrinol (Oxf); 2006 Aug; 65(2):250-6. PubMed ID: 16886969
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Diagnostic value of the L-dopa test].
    Migdalska B; Wiśniewska-Woźniak T; Baranowska B; Kasperlik-Zaluska A; Olesińska J
    Endokrynol Pol; 1976; 27(3):265-74. PubMed ID: 1278129
    [No Abstract]   [Full Text] [Related]  

  • 8. Adrenergic modulation of growth hormone secretion in acromegaly: alpha- and beta-adrenergic blockade produce qualitatively normal responses but no effect on L-dopa suppresion.
    Cryer PE; Daughaday WH
    J Clin Endocrinol Metab; 1977 May; 44(5):977-9. PubMed ID: 870520
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Reevaluation of the I-dopa test in acromegaly: anatomo-clinical and prognostic correlations].
    De Marinis L; Mancini A; Zuppi P; Fiumara C; Iacona T; Conte G; Fabrizi ML; Valle D; Anile C; Maira G
    Minerva Chir; 1993 Nov; 48(21-22):1337-40. PubMed ID: 8152567
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [L-dopa provocative test].
    Takeda S; Inoue K
    Nihon Rinsho; 1997 Apr; 55 Suppl 2():229-33. PubMed ID: 9172513
    [No Abstract]   [Full Text] [Related]  

  • 11. Inhibition of L-dopa induced growth hormone release in normal and diabetic subjects by glucose administration.
    Vigas M; Klimes I; Jurcovicova J; Kolesar P; Repcekova-Jezova D
    Diabete Metab; 1977 Dec; 3(4):257-8. PubMed ID: 598566
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The diagnostic value of the propranolol-glucagon test for somatotropin secretion].
    Protich M; Petkova M; Tsanev A
    Vutr Boles; 1989; 28(4):70-2. PubMed ID: 2596109
    [No Abstract]   [Full Text] [Related]  

  • 13. Predicting long-term remission by measuring immediate postoperative growth hormone levels and oral glucose tolerance test in acromegaly.
    Kim EH; Oh MC; Lee EJ; Kim SH
    Neurosurgery; 2012 May; 70(5):1106-13; discussion 1113. PubMed ID: 22067418
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transient appearance of a provocative growth hormone response to L-dopa following incomplete adenomectomy in an acromegalic patient.
    Takahara J; Yakushiji W; Yamuchi J; Miyoshi M; Hosogi H
    J Clin Endocrinol Metab; 1977 Mar; 44(3):599-602. PubMed ID: 838854
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carbidopa inhibits the growth hormone- and prolactin-suppressive effect of L-dopa in acromegalic patients.
    Camanni F; Picotti GB; Massara F; Molinatti GM; Mantegazza P; Müller EE
    J Clin Endocrinol Metab; 1978 Sep; 47(3):647-52. PubMed ID: 263317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Growth hormone inhibitory and stimulatory actions of L-dopa in patients with acromegaly.
    Hanew K; Sasaki A; Sato S; Goh M; Yoshinaga K
    J Clin Endocrinol Metab; 1987 Feb; 64(2):255-60. PubMed ID: 3793848
    [TBL] [Abstract][Full Text] [Related]  

  • 17. L-dopa stimulation at growth hormone release in normal subjects and in patients with Sheehan's syndrome.
    Himathongkam T; Tiyapan A; Rajatanavin R; Pitchayayothin N
    J Med Assoc Thai; 1981 Jan; 64(1):19-25. PubMed ID: 7217816
    [No Abstract]   [Full Text] [Related]  

  • 18. [Hormonal evaluation of 27 patients with acromegaly].
    Villabona C; Novials A; Soler J; Morató J; Gómez JM; Navarro MA
    Med Clin (Barc); 1985 Feb; 84(6):219-22. PubMed ID: 3920452
    [No Abstract]   [Full Text] [Related]  

  • 19. [Diagnostic value of hGH glucose suppression test in acromegaly (author's transl)].
    Deng JY
    Zhonghua Nei Ke Za Zhi; 1981 Aug; 20(8):467-70. PubMed ID: 7338080
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of thyrotropin-releasing hormone on growth hormone release in normal subjects and in patients with depression, anorexia nervosa and acromegaly.
    Maeda K
    Kobe J Med Sci; 1976 Dec; 22(4):263-72. PubMed ID: 829578
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.